Viamet files for IPO; withdrawn; later revived; postpones once again
After initially filing for its IPO in June 2014 and then withdrawing the offering four months later, antifungals developer Viamet Pharmaceuticals Corp. (formerly Viamet Pharmaceuticals Holdings LLC) is attempting to go public again.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.